查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786990

Naltrexone·Buprenornhine(纳曲酮和丁丙诺啡)市场，规模，占有率，趋势，产业分析报告:各产品，各给药途径，各用途，各流通管道，各地区-2025年～2034年市场预测

Naltrexone and Buprenorphine Market Size, Share, Trends, Industry Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration, By Application, By Distribution Channel, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，纳曲酮和丁丙诺啡市场规模预计到 2034 年将达到 124 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

纳曲酮和丁丙诺啡是用于治疗鸦片类药物使用障碍的药物，其作用是减少药物渴求并预防復发。阿片类药物使用疾患的治疗正从短期戒毒转向长期康復计画。医疗保健专业人士认识到，持续的药物治疗可以改善康復效果并降低復发风险。纳曲酮和丁丙诺啡均用于长期治疗策略，因为它们可以维持治疗参与度并降低復发的可能性。随着越来越多的治疗中心采用长期治疗方案，对可以长期安全服用的药物的需求也日益增长。这一趋势支持在各种治疗环境中持续使用这两种药物。

传统上，阿片类药物使用疾患的治疗主要由成瘾专家提供，但这种情况正在改变。现在，越来越多的初级保健提供者和全科医生提供纳曲酮和丁丙诺啡的药物辅助治疗。这部分归功于处方限制的放宽以及对非专科医生培训的加强。现在患者可以从他们的常规医生那里接受治疗，这使得治疗更容易获得。这种转变有助于将鸦片类药物使用障碍 (OUD) 治疗纳入常规医疗保健，从而增加能够开始并继续接受治疗的患者数量。随着可近性越来越广泛，预计这些药物的使用将继续增加。

纳曲酮与丁丙诺啡市场报告重点

到2024年，丁丙诺啡市场将占据显着占有率，因为它广泛应用于控制阿片类药物戒断症状和减少药物渴求。

预计在预测期内，医院药局市场将大幅成长，因为它是药物过量和戒断症状患者的第一个护理点。

到2024年，北美将占据纳曲酮和丁丙诺啡市场的最大占有率，这得益于阿片类药物使用障碍的高发病率以及政府对扩大治疗可及性的坚定承诺。

由于人们对物质使用障碍的认识不断提高以及加强精神卫生服务的力度，亚太地区的纳曲酮和丁丙诺啡市场正在经历显着增长。

全球主要市场参与者包括 Alkermes, Inc.、Camurus、Collegium Pharmaceutical、Indivior PLC、Orexo US, Inc.（Orexo AB 的子公司）、Sun Pharmaceutical Industries Ltd. 和 Titan Pharmaceuticals, Inc.。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球Naltrexone·Buprenornhine市场洞察

  • 市场概述
  • Naltrexone·Buprenornhine的市场动态
    • 促进因素和机会
      • 类鸦片物质使用障碍患者的增加
      • 政府的辅助政策与计划
    • 阻碍因素与课题
      • 初期投资额提高
  • PESTEL分析
  • Naltrexone·Buprenornhine的市场趋势
  • 价值链分析

第5章 全球Naltrexone·Buprenornhine市场:各产品

  • 主要调查结果
  • 简介
  • Naltrexone
  • Buprenornhine

第6章 全球Naltrexone·Buprenornhine市场:各给药途径

  • 主要调查结果
  • 简介
  • 口服给药
  • 注射剂给药
  • 置入式给药

第7章 全球Naltrexone·Buprenornhine市场:各用途

  • 主要调查结果
  • 简介
  • 类鸦片物质使用障碍(OUD)
  • 酒精使用障碍(AUD)

第8章 全球Naltrexone·Buprenornhine市场:各流通管道

  • 主要调查结果
  • 简介
  • 医院药局
  • 零售药局
  • 其他

第9章 全球Naltrexone·Buprenornhine市场:各地区

  • 主要调查结果
  • 简介
    • Naltrexone·Buprenornhine的市场评估:地区，2020年～2034年
  • 北美
    • 北美:各产品，2020年～2034年
    • 北美:各给药途径，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020年～2034年
    • 欧洲:各给药途径，2020年～2034年
    • 欧洲:各用途，2020年～2034年
    • 欧洲:各流通管道，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020年～2034年
    • 亚太地区:各给药途径，2020年～2034年
    • 亚太地区:各用途，2020年～2034年
    • 亚太地区:各流通管道，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020年～2034年
    • 中东·非洲:各给药途径，2020年～2034年
    • 中东·非洲:各用途，2020年～2034年
    • 中东·非洲:各流通管道，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品，2020年～2034年
    • 南美:各给药途径，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Alkermes, Inc.
  • Camurus
  • Collegium Pharmaceutical
  • Indivior PLC
  • Orexo US, Inc.(a part of Orexo AB)
  • Sun Pharmaceutical Industries Ltd
  • Titan Pharmaceuticals, Inc.
Product Code: PM5962

The naltrexone and buprenorphine market size is expected to reach USD 12.40 billion by 2034, according to a new study by Polaris Market Research. The report "Naltrexone and Buprenorphine Market Size, Share, Trends, Industry Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration, By Application, By Distribution Channel, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Naltrexone and buprenorphine are medications used to treat opioid use disorder by reducing cravings and preventing relapse. There is a shift in how opioid use disorder is being treated from short-term detox to long-term recovery planning. Healthcare professionals now recognize that continued medication support can improve recovery outcomes and lower relapse risks. Naltrexone and buprenorphine are both used in long-term treatment strategies because they help people stay engaged in care and reduce the chance of returning to drug use. As more treatment centers adopt a long-term approach, the need for medications that can be taken safely over time increases. This trend supports continued growth in the use of both medications across various care settings.

Traditionally, treatment for opioid use disorder was handled mostly by addiction specialists, but this is changing. Now, more primary care providers and general practitioners are offering medication-assisted treatment using naltrexone and buprenorphine. This is partly due to reduced prescribing restrictions and increased training for non-specialists. Patients can now receive treatment from their regular doctors, making it easier to access care. This shift is helping integrate OUD treatment into everyday healthcare, which increases the number of patients who can start and continue treatment. As access widens, use of these medications is expected to keep rising.

Naltrexone and Buprenorphine Market Report Highlights

In 2024, the buprenorphine segment dominated with a larger share due to its widespread use in managing opioid withdrawal symptoms and reducing cravings.

The hospitals pharmacies segment is expected to experience significant growth during the forecast period, as hospitals are the first point of care for individuals experiencing overdose or withdrawal.

In 2024, North America dominated the naltrexone and buprenorphine market with the largest share driven by the high prevalence of opioid use disorder and strong government involvement in expanding access to treatment.

The Asia Pacific naltrexone and buprenorphine market is experiencing significant growth, due to growing awareness of substance use disorders and efforts to strengthen mental health services.

A few global key market players are Alkermes, Inc.; Camurus; Collegium Pharmaceutical; Indivior PLC; Orexo US, Inc. (a part of Orexo AB); Sun Pharmaceutical Industries Ltd; and Titan Pharmaceuticals, Inc.

Polaris market research has segmented the naltrexone and buprenorphine market report based on product, route of administration, application, distribution channel, and region:

By Product (Revenue - USD Billion, 2020-2034)

Naltrexone

Buprenorphine

BELBUCA

Sublocade

Suboxone

Zubsolv

Others

By Route of Administration (Revenue - USD Billion, 2020-2034)

Oral Administration

Injectable Administration

Implantable Administration

By Application (Revenue - USD Billion, 2020-2034)

Opioid Use Disorder (OUD)

Alcohol Use Disorder (AUD)

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospitals Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Naltrexone And Buprenorphine Market Insights

  • 4.1. Naltrexone And Buprenorphine Market - Market Snapshot
  • 4.2. Naltrexone And Buprenorphine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Number of People with Opioid Use Disorder
      • 4.2.1.2. Supportive Government Policies and Programs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Naltrexone And Buprenorphine Market Trends
  • 4.6. Value Chain Analysis

5. Global Naltrexone And Buprenorphine Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 5.3. Naltrexone
    • 5.3.1. Global Naltrexone And Buprenorphine Market, by Naltrexone, by Region, 2020-2034 (USD billion)
  • 5.4. Buprenorphine
    • 5.4.1. Global Naltrexone And Buprenorphine Market, by Buprenorphine, by Region, 2020-2034 (USD billion)
    • 5.4.2. BELBUCA
      • 5.4.2.1. Global Naltrexone And Buprenorphine Market, by BELBUCA, by Region, 2020-2034 (USD billion)
    • 5.4.3. Sublocade
      • 5.4.3.1. Global Naltrexone And Buprenorphine Market, by Sublocade, by Region, 2020-2034 (USD billion)
    • 5.4.4. Suboxone
      • 5.4.4.1. Global Naltrexone And Buprenorphine Market, by Suboxone, by Region, 2020-2034 (USD billion)
    • 5.4.5. Zubsolv
      • 5.4.5.1. Global Naltrexone And Buprenorphine Market, by Zubsolv, by Region, 2020-2034 (USD billion)
    • 5.4.6. Others
      • 5.4.6.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Naltrexone And Buprenorphine Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 6.3. Oral Administration
    • 6.3.1. Global Naltrexone And Buprenorphine Market, by Oral Administration, by Region, 2020-2034 (USD billion)
  • 6.4. Injectable Administration
    • 6.4.1. Global Naltrexone And Buprenorphine Market, by Injectable Administration, by Region, 2020-2034 (USD billion)
  • 6.5. Implantable Administration
    • 6.5.1. Global Naltrexone And Buprenorphine Market, by Implantable Administration, by Region, 2020-2034 (USD billion)

7. Global Naltrexone And Buprenorphine Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Naltrexone And Buprenorphine Market, by Medical Biotechnology, 2020-2034 (USD billion)
  • 7.3. Opioid use disorder (OUD)
    • 7.3.1. Global Naltrexone And Buprenorphine Market, by Opioid use disorder (OUD), by Region, 2020-2034 (USD billion)
  • 7.4. Alcohol use disorder (AUD)
    • 7.4.1. Global Naltrexone And Buprenorphine Market, by Alcohol use disorder (AUD), by Region, 2020-2034 (USD billion)

8. Global Naltrexone And Buprenorphine Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.3. Hospitals Pharmacies
    • 8.3.1. Global Naltrexone And Buprenorphine Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Naltrexone And Buprenorphine Market, by Retail Pharmacies, by Region, 2020-2034 (USD billion)
  • 8.5. Others
    • 8.5.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

9. Global Naltrexone And Buprenorphine Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Naltrexone And Buprenorphine Market - North America
    • 9.3.1. North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.3.2. North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.3.3. North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.3.4. North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.3.5. Naltrexone And Buprenorphine Market - US
      • 9.3.5.1. US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.3.5.2. US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.3.5.3. US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.3.5.4. US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.3.6. Naltrexone And Buprenorphine Market - Canada
      • 9.3.6.1. Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4. Naltrexone And Buprenorphine Market - Europe
    • 9.4.1. Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.2. Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.3. Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.4. Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.5. Naltrexone And Buprenorphine Market - UK
      • 9.4.5.1. UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.6. Naltrexone And Buprenorphine Market - France
      • 9.4.6.1. France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.6.2. France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.6.3. France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.6.4. France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.7. Naltrexone And Buprenorphine Market - Germany
      • 9.4.7.1. Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.8. Naltrexone And Buprenorphine Market - Italy
      • 9.4.8.1. Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.9. Naltrexone And Buprenorphine Market - Spain
      • 9.4.9.1. Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.10. Naltrexone And Buprenorphine Market - Netherlands
      • 9.4.10.1. Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.11. Naltrexone And Buprenorphine Market - Russia
      • 9.4.11.1. Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.12. Naltrexone And Buprenorphine Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5. Naltrexone And Buprenorphine Market - Asia Pacific
    • 9.5.1. Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.5. Naltrexone And Buprenorphine Market - China
      • 9.5.5.1. China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.5.2. China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.5.3. China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.5.4. China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.6. Naltrexone And Buprenorphine Market - India
      • 9.5.6.1. India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.6.2. India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.6.3. India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.6.4. India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.7. Naltrexone And Buprenorphine Market - Malaysia
      • 9.5.7.1. Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.8. Naltrexone And Buprenorphine Market - Japan
      • 9.5.8.1. Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.9. Naltrexone And Buprenorphine Market - Indonesia
      • 9.5.9.1. Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.10. Naltrexone And Buprenorphine Market - South Korea
      • 9.5.10.1. South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.11. Naltrexone And Buprenorphine Market - Australia
      • 9.5.11.1. Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.12. Naltrexone And Buprenorphine Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6. Naltrexone And Buprenorphine Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.5. Naltrexone And Buprenorphine Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.6. Naltrexone And Buprenorphine Market - UAE
      • 9.6.6.1. UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.7. Naltrexone And Buprenorphine Market - Israel
      • 9.6.7.1. Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.8. Naltrexone And Buprenorphine Market - South Africa
      • 9.6.8.1. South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.9. Naltrexone And Buprenorphine Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7. Naltrexone And Buprenorphine Market - Latin America
    • 9.7.1. Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.5. Naltrexone And Buprenorphine Market - Mexico
      • 9.7.5.1. Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.6. Naltrexone And Buprenorphine Market - Brazil
      • 9.7.6.1. Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.7. Naltrexone And Buprenorphine Market - Argentina
      • 9.7.7.1. Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.8. Naltrexone And Buprenorphine Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alkermes, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Camurus
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Collegium Pharmaceutical
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Indivior PLC
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Orexo US, Inc. (a part of Orexo AB)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Sun Pharmaceutical Industries Ltd
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Titan Pharmaceuticals, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development

List of Tables:

  • Table 1 Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 2 Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 3 Global Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 4 Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 5 North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 6 North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 7 North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 8 North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 9 US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 10 US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 11 US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 12 US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 13 Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 14 Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 15 Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 16 Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 17 Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 18 Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 19 Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 20 Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 21 UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 22 UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 23 UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 24 UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 25 France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 26 France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 27 France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 28 France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 29 Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 30 Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 31 Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 32 Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 33 Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 34 Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 35 Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 36 Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 37 Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 38 Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 39 Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 40 Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 41 Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 42 Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 43 Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 44 Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 45 Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 46 Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 47 Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 48 Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 49 Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 50 Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 51 Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 52 Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 53 Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 54 Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 55 Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 56 Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 57 China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 58 China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 59 China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 60 China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 61 India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 62 India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 63 India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 64 India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 65 Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 66 Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 67 Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 68 Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 69 Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 70 Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 71 Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 72 Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 73 Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 74 Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 75 Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 76 Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 77 South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 78 South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 79 South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 80 South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 81 Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 82 Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 83 Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 84 Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 85 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 86 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 87 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 88 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 89 Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 90 Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 91 Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 92 Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 93 Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 94 Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 95 Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 96 Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 97 UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 98 UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 99 UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 100 UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 101 Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 102 Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 103 Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 104 Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 105 South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 106 South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 107 South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 108 South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 109 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 110 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 111 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 112 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 113 Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 114 Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 115 Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 116 Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 117 Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 118 Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 119 Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 120 Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 121 Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 122 Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 123 Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 124 Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 125 Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 126 Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 127 Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 128 Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 129 Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 130 Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 131 Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 132 Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Naltrexone And Buprenorphine Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Naltrexone And Buprenorphine Market, by Product, 2024 & 2034 (USD billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2024 & 2034 (USD billion)
  • Figure 10. Market by Application
  • Figure 11. Global Naltrexone And Buprenorphine Market, by Application, 2024 & 2034 (USD billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2024 & 2034 (USD billion)
  • Figure 14. Global Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 15. Strategic Analysis - Global Naltrexone And Buprenorphine Market